Investigating the Effect of Ivabradine Drug on Controlling the Ventricular Response in Atrial Fibrillatio
Phase 2
- Conditions
- Atrial fibrillation.Atrial fibrillation and flutter
- Registration Number
- IRCT20240207060933N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with permanent or persistent AF
Heart rate greater than 100 beats per minute at rest.
Exclusion Criteria
Age less than 18 years
Pregnant women
Women who breastfeed their children
Patients with acute liver and kidney failure
Lack of consent to start or continue the treatment process
Patients with uncontrolled blood pressure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ventricular Response. Timepoint: one month. Method of measurement: ECG Holter.
- Secondary Outcome Measures
Name Time Method